Medical insurance brokers have applauded moves by private medical insurance (PMI) providers to remove the limits on cancer coverage for many standard polices.
It comes after yesterday's announcement by Axa PPP that it had removed all cost and time limits for licensed cancer drug treatment for patients on standard individual and SME plans. This was in response to Aviva's move in October to cover cancer treatments recommended by specialists in full and also extend coverage to include non-NHS drugs one related treatments and scans and rehabilitation. The Association of Medical Insurance Intermediaries (AMII) gave its approval to both moves, calling Axa PPP's review of its heart disease and cancer coverage ‘positive', following on from Aviva's ...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
